Factors underlying cognitive decline in old age and Alzheimer's disease: the role of the hippocampus. by Jaroudi, Wafa et al.
Rev. Neurosci. 2017; 28(7): 705–714
Wafa Jaroudi, Julia Garami, Sandra Garrido, Michael Hornberger, Szabolcs Keri  
and Ahmed A. Moustafa*
Factors underlying cognitive decline in old 
age and Alzheimer’s disease: the role of the 
hippocampus
DOI 10.1515/revneuro-2016-0086
Received December 22, 2016; accepted February 18, 2017;  previously 
published online April 19, 2017
Abstract: There are many factors that strongly influence 
the aetiology, development, and progression of cognitive 
decline in old age, mild cognitive impairment (MCI), and 
Alzheimer’s disease (AD). These factors include not only 
different personality traits and moods but also lifestyle 
patterns (e.g. exercise and diet) and awareness levels 
that lead to cognitive decline in old age. In this review, we 
discuss how personality traits, mood states, and lifestyle 
impact brain and behaviour in older adults. Specifically, 
our review shows that these lifestyle and personality fac-
tors affect several brain regions, including the hippocam-
pus, a region key for memory that is affected by cognitive 
decline in old age as well as AD. Accordingly, appropriate 
recommendations are presented in this review to assist 
individuals in decreasing chances of MCI, dementia, AD, 
and associated symptoms.
Keywords: Alzheimer’s disease; cognitive decline; hip-
pocampus; lifestyle; memory; mood states; personality.
Introduction
The occurrence of cognitive decline in old age depends 
on many differences among individuals. In this study, we 
review research addressing personality, mood, and life-
style factors underlying cognitive decline in old age that 
may vary across individuals. Identifying these factors will 
help therapists address such factors at a younger age, thus 
reducing chances of developing old-age-related neuro-
logical disorders. Cognitive decline in later life commonly 
occurs as part of a range of neurological conditions that 
come under the umbrella term of dementia. Alzheimer’s 
dementia (AD) is the most common form of dementia, 
with no cure existing today. It has a higher occurrence rate 
in females than in males (approximately 56% and 31.4%, 
respectively) and often occurs in individuals 65  years or 
older (Alzheimer’s Association, 2014). AD is also a common 
cause of death in elderly individuals (National Institute on 
Aging, 2015). Like healthy ageing, various individual dif-
ferences impact the progression of AD, including lifestyle 
(e.g. type of diet and amount of exercise) and personality 
(e.g. neuroticism and exposure to/coping with stress).
In this review, we explore the evidence for lifestyle 
and personality traits that influence individuals’ rate of 
cognitive decline in old age as well as onset of AD patho-
physiology. In addition, we consider emotional states 
associated with sadness, stress, and loneliness, which 
also lead to mild cognitive impairment (MCI) and AD 
symptoms. Moreover, older adults’ and AD patients’ life-
styles such as diet and exercise patterns will be discussed, 
as well as how lifestyle can improve or worsen cognitive 
function and disease progression.
Personality effect on cognitive 
decline
Neuroticism
Personality traits such as neuroticism generally have neg-
ative impacts on normal functioning; they may be linked 
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to increased risks of developing cognitive decline and 
dementia (Archer et al., 2009). Neuroticism is a personal-
ity trait characterised by moodiness, anger, fear, anxiety, 
and jealousy, among others. According to Chapman 
et  al. (2012), older individuals scoring high on neuroti-
cism scales but low on openness (e.g. being accepting of 
change) and conscientiousness (e.g. being careful, organ-
ised, and mindful) scales exhibit poor long-term cogni-
tive functioning and steeper rates of cognitive decline 
(Chapman et al., 2012). A possible explanation for cogni-
tive decline in old age is hippocampal atrophy related to 
glucocorticoid drugs (Sapolsky, 1996) such as chronically 
elevated cortisol levels (Chapman et al., 2012). Increased 
cortisol has been associated with stress characteristics of 
negative affect (Buchanan et al., 1999), which may relate 
to neuroticism. In addition, emotional stress and glucocor-
ticoids (associate characteristics of neuroticism) may also 
lead to structural changes in the hippocampus (atrophy 
and volume loss), further contributing to cognitive decline 
(Gurvits et  al., 1996; McEwen, 2000; Boyle et  al., 2010). 
Changes in these personality domains are significantly 
high in AD patients, where premorbid personality traits 
have a moderate association with levels of cognitive func-
tioning, and functioning in daily life (Chapman et  al., 
2012).
In females, midlife neuroticism seems to be asso-
ciated with the early onset of dementia (Archer et  al., 
2009). In comparison to males, female midlife neu-
roticism may be accounted for by lower levels of the 
hormone oestrogen at menopause (considering that AD 
usually occurs after the mean age of 65  years). If not 
managed, stress can develop into distress, increasing 
risks of cognitive decline, impairment, and also AD 
(Wilson et al., 2007a).
Neuroticism, in comparison to other personality 
traits, can be suggested to present with elevated activity 
of the limbic brain (Newbery, 2012), which includes the 
hippocampus, dentate gyrus, cornuammonis, amygdala, 
basal ganglia, as well as other regions. The limbic system 
related to emotion and memory involves the amygdala 
and hippocampus. A correlation between activation levels 
in the amygdala and hippocampus (Poulin et  al., 2011) 
suggests that atrophy in both may relate to less emotional 
reactivity in general and in association to memories. 
During mild AD, it is noted that amygdala activity is most 
associated with elevated emotions such as irritability and 
anxiety (Poulin et al., 2011), which highlights the function 
of brain alterations that occur in the hippocampus related 
to neuroticism and cognitive decline in AD (Boyle et al., 
2010).
Mood and emotional state effect on 
cognitive decline
Loneliness
Prolonged feelings of loneliness can harm individuals in 
many ways. Loneliness can lead to depression and higher 
risk of death (Holwerda et  al., 2016). Feeling lonely can 
sometimes also lead to thoughts of being a burden or a 
liability on family and friends (Davis, 2014). Addition-
ally, although patients with amnesia (and probably AD) 
show memory decline, they still feel emotions associated 
with memories (University of Iowa, 2010). In an attempt 
to improve patient rate of cognitive decline, it could 
be suggested to improve patients’ psychological well-
being, including stress levels. This can include providing 
comfort, care, and intimacy. Care is necessary for patients 
to feel understood and appreciated by others, especially by 
family, caregivers, nurses, and friends (Anderson, 2007). 
Observations indicate that loneliness doubles the risks of 
late-life AD-like dementia (Wilson et al., 2007b); however, 
there have been mixed findings. Autopsies suggest that 
loneliness is not related to AD or cerebral infarction 
(Wilson et al., 2007b). However, we believe that although 
the impact of loneliness may not be directly observable, it 
can influence depression, stress, and similar factors that 
do have direct impacts on cognition. As such, it is reported 
that depression associated with loneliness may be a con-
tributing factor of AD development (Tanday, 2007).
Stress
Stress and distress (including anxiety) can have many 
health implications. This includes increased risks and 
exacerbation of cognitive decline and functioning, MCI, 
and AD (Wilson et  al., 2005, 2007a, 2011). This may be 
explained in part by stress-related release of the hormone 
cortisol, as it has been found that extreme stress leading 
to excessive release of cortisol affects the hippocampus 
(Gurvits et  al., 1996; Buchanan et  al., 1999; McEwen, 
2000). Extreme elevated cortisol levels influence hip-
pocampal function and result in impaired cognition, spe-
cifically memory (Archer et al., 2009). Reviewing research 
in the previous section on the personality trait of neuroti-
cism and now, stress, it is notable that a high level of corti-
sol is common in the two. The linkage concerns increased 
cortisol leading to hippocampal atrophy (Chapman 
et al., 2012), which consequently contributes to memory 
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declination (Archer et  al., 2009). To reduce stress and 
cortisol levels and their impact on cognition, we suggest 
that individuals switch to a healthy diet and participate in 
exercise regularly as part of a healthy lifestyle.
Stress is also a significant risk factor of amnestic MCI 
(aMCI). In a study conducted by Katz et al. (2016), partici-
pants were assessed 3 years after initial risk assessment 
of aMCI. It was found that the risk of developing aMCI 
increased by 30% per five-point score on the Perceived 
Stress Scale. Participants with scores in the 80th percen-
tile were almost 2.5 times more likely to develop aMCI over 
this time.
Moreover, females often express higher rates of dis-
tress, which is associated with a decline in cognitive func-
tioning over an average of 5  years (Wilson et  al., 2005). 
Increased experience of stress in females may explain why 
worse cognitive functioning is more common in females 
than in males (Wilson et al., 2005).
As well as increasing the risk of cognitive decline, 
negative mood states and experiences involving stress, 
anxiety, and so on may also contribute to an acceleration 
of cognitive decline in people with diagnoses of various 
forms of dementia (Wilson et al., 2005). Chronic distress 
and emotional states (including misery and agony) are 
common in AD patients. Irritability, agitation, and similar 
emotions also contribute to worse AD patient health and 
may also affect cognition (Hurt et al., 2010). High levels 
of continual distress are associated with decline in mul-
tiple cognitive functions, primarily episodic memory 
(Wilson et  al., 2007a). Moreover, chronic distress is also 
linked to higher rates of MCI. In addition to an association 
with global cognitive impairment, chronic distress is also 
related to limbic system functioning (Wilson et al., 2007a). 
However, chronic distress is suspected to specifically 
influence certain aspects of cognition more than others, 
predominantly episodic memory (Wilson et  al., 2007a). 
This association between chronic distress and memory 
may be tied to the relationship between the hippocampus 
and limbic system. The anatomic structure of the limbic 
cortex is connected with the hippocampus; therefore, if 
the limbic system is altered by stress, the hippocampus 
may also be affected, likely to disrupt memory (Tortora 
and Derrickson, 2006). This reflects a chain-like link or 
hierarchical structure where all factors associated with 
cognitive decline lead or contribute to one another.
Studies of posttraumatic stress disorder (PTSD) 
patients may additionally help shed light on the connec-
tion between stress, distress, and cognitive decline. There 
are increased risks of developing dementia in male vet-
erans under the age of 75 with PTSD (Yaffe et al., 2010), 
which suggests that an individual’s stressful life experi-
ences increase the likelihood of developing neurodegen-
erative diseases. An increased risk of disease development 
has been attributed to damage to hippocampal structures. 
Suffering from head injury, witnessing traumatic events, 
and experiencing chronic stress can damage or shrink the 
hippocampus, causing disruption to learning and memory 
(Yaffe et al., 2010). Stressful experiences tend to overlap 
with ongoing anxiety, which is very common in elderly 
individuals with cognitive decline and dementia (Bierman 
et al., 2007). As anxiety increases, so does global cognitive 
decline, making individuals more prone to stress (Wilson 
et al., 2011). Moreover, cognitive decline is related to the 
amount of stress an individual experiences, increasing the 
chances of developing AD (Wilson et al., 2011).
Depressive symptoms
Individuals experiencing depression are suggested to also 
score high on neuroticism (Farmer et al., 2002), highlight-
ing the importance of considering both factors in AD. It is 
proposed that depression is associated with hippocampal 
volume loss (Sheline et al., 2003) and contributes to cog-
nitive decline and dementia (Yaffe et al., 1999). However, 
much of the literature consider depression and stress and 
their associated emotions separately when assessing and 
evaluating individual’s mental well-being, cognition, and 
risk of AD, despite the fact that such emotional psycho-
logical states are closely related (Nima et  al., 2013). We 
attempt to bridge this gap by discussing the mentioned 
states and emotions, considering their pathological 
symptoms, and suggesting strategies for minimising the 
effect of psychological distress on individuals in mid and 
late life.
Depression has been found to be a contributing factor 
to dementia and AD (Cherbuin et al., 2015). In elderly indi-
viduals’ assessments of depression, each point increase 
on the Center for Epidemiological Studies Depression/
Hamilton Depression Scale (CES-D/HAM) contributes to 
a 5% increase risk of dementia over a period of 5.2 years 
(Cherbuin et al., 2015). Furthermore, scores above 20/21 on 
the CES-D and similar scales used to measure depression 
are linked to an 83% increase in the risk of dementia, after 
an 8.2-year follow-up. Similarly, a one-point increase on 
the CES-D/HAM was found to increase AD development by 
6% over a 5.9-year period (Cherbuin et al., 2015). In more 
detail, Cherbuin et al. (2015) also note that scores above 
20/21 on the CES-D is linked to a 97% risk increase of AD 
over 6.3  years. These findings are also where dementia 
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patients tend to score high on the CES-D (Fuhrer et  al., 
2003), implying that depression is related to cognitive 
decline and dementia development.
Depression is suggested to also relate to pathological 
issues such as neuroinflammation, oxidative stress, white 
matter lesions, and cerebral atrophy (Cherbuin et  al., 
2015). Such pathological issues are evident even in young 
individuals with depression. Therefore, for practitioners 
to minimise chances of developing dementia and AD at 
a young age, it would be best to consider the cause, treat-
ment, and management of pathological issues linked with 
the development of depression. In fact, it has been argued 
that a 25% reduction in depression prevalence could 
result in 827 000 fewer cases of AD worldwide (Barnes 
and Yeffe, 2011). While managing depression, it should 
be noted that verbal types of therapy may not be across 
the board effective because individuals respond differ-
ently to forms of therapy. For example, elderly and young 
males are less likely to engage in emotion talk therapy or 
even seek support from such therapies (Anderson and 
Brownlie, 2011). Therefore, it may be more beneficial for 
individuals to seek support from a wider range of thera-
pies. For instance, in mild and moderate dementia, music 
therapy not only assists individuals to cope with and 
reduce depressive symptoms but also improves cognitive 
functioning and processes (mainly recall) in a positive 
and effective manner (Chu et al., 2014).
Apathy, an affective state involving a lack of inter-
est, also affects cognition. Although apathy and depres-
sion are different, they can co-occur but are reliant on 
different neural mechanisms. As mentioned previously, 
it is important to account for factors such as depression 
and apathy as occurring if not combined, then hierarchi-
cally in dementia development. Depression and apathy 
may relate to each other on the basis of similar emotional 
affects (Benoit et  al., 2012). This is supported by the 
finding that depressed individuals tend to exhibit apathy, 
and individuals with apathy tend also to show depres-
sive symptoms (Benoit et  al., 2012). Therefore, we could 
suggest a unique symptom representative of the overlap 
between depression and apathy (Benoit et  al., 2012) in 
cognitive decline. Regarding neuropathological effects of 
apathy, highly apathetic patients develop cortical ema-
ciation in the caudal anterior cingulated cortex, lateral 
orbitofrontal cortex, and pars triangularis where neurofi-
brillary tangles occur (Tunnard et  al., 2011). Changes in 
these brain regions are suggested to contribute to cortical 
thinning of the left anterior cingulate, affecting memory 
among other cognitive processes (Tunnard et  al., 2011). 
Therefore, it is hypothesised that the underlying psy-
chopathological mechanism connecting apathy and 
depression with cognition is the role of the anterior cin-
gulated cortex (ACC). It could be suggested that damage to 
the ACC affects emotional experience and expression, as 
well as cognitive functions like learning.
Awareness of one’s disease (AD), also known as 
insight, has been associated with depression, anxiety, 
and apathy (Horning et  al., 2014). Insight is defined as 
one’s self-understanding, knowledge, and awareness of 
cognitive decline, impairment, and disease diagnosis. On 
the other hand, anosognosia is the lack of knowing and 
understanding one’s own cognitive and functional diffi-
culties. In elderly individuals and AD patients, anosogno-
sia can limit some abilities, leading to risky and harmful 
behaviour (e.g. unknowingly overdosing on medications 
or accidentally keeping the stove on high heat, causing 
a fire) (Starkstein et  al., 2007). Risky behaviour may be 
related to the idea that AD patients experience prob-
lems with verbal comprehension, fluency, and construc-
tional praxis, which may be linked to completing certain 
processes and functions in a proper and safe manner 
( Starkstein et al., 2007). Impairment in aspects of cogni-
tion is influenced by patients’ awareness and knowledge 
of their physical and mental health. Lack of self-knowl-
edge continues to degrade with cognitive functioning, 
as supported by Mini-Mental State Examination (MMSE) 
scores (Hurt et al., 2010). With continued lack of insight 
and cognition, anxiety levels start to decrease because 
anxiety invoking experiences start to have no significant 
emotional effect (Bierman et al., 2007).
Distinguishing cognitive decline 
from typical mood state symptoms
Many individuals in mid and late life exhibit neuroticism 
and experience loneliness or stress. However, it is impera-
tive to distinguish between symptoms inherent to aging 
and those indicative of reversible or solvable loneliness, 
stress, and depression. In doing so, it is vital to consider 
both observable behaviour and neurological changes. 
For example, clinicians often ask if patients are feeling 
depressed and if they complain of memory problems. If 
depressed, it is likely that they do not have dementia, 
as depression has a major impact on episodic memory 
functioning.
When investigating the differences between physi-
cal symptoms of mood changes and age-related cognitive 
decline, it is important to monitor amygdala activity and 
hippocampal changes. This includes observing expres-
sions of irritability and anxiety (Poulin et  al., 2011) as 
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indicative of possible signs of the cognitive aging process. 
It may be possible that if all factors of amygdala activity, 
hippocampal changes, and expressions of irritability and 
anxiety occur together or are subsequent to each other, 
individuals may be in the early stages of behavioural and 
cognitive decline. If this is found not to be the case, it is 
essential to consider other factors such as environment. 
For example, individuals’ living spaces are another impor-
tant factor in cognition as a lonely environment may con-
tribute to global cognitive impairment (O’Luanaigh et al., 
2012). It is also important to not only note individuals’ 
emotional experiences of loneliness but also test memory 
loss (University of Iowa, 2010) and assess individuals for 
stress and depression, and compare scale scores to that of 
MMSE scores (Wilson et al., 2005; Katz et al., 2016).
An additional approach to distinguishing temporary 
reversible emotional states and moods from those that 
are age induced is to consider the crucial aspects of cor-
tisol levels and brain alterations, such as increased risk 
of dementia, atrophy, and lesions to regions of the limbic 
system such as the hippocampus, amygdala, and ACC 
(Tunnard et al., 2011; Chapman et al., 2012). Such assess-
ments will assist researchers and therapists to identify 
whether an individual is experiencing cognitive impair-
ment that is induced by reversible, temporary, or environ-
mental factors (pseudo-dementia) rather than confusing 
it with other types of dementia (AD).
Lifestyle factors in cognitive decline
Nutrition
Diet has been found to be related to cognitive decline 
(Nurk et al., 2007). There is evidence that tea, fish, fruits, 
nuts, and turmeric (curcumin) may protect against demen-
tia (Nurk et al., 2007; Mishra and Palanivelu, 2008; Chen 
et al., 2011; Pe’neau et al., 2011; Poulose et al., 2014; Qin 
et al., 2014; Cardoso et al., 2016). It is suggested that vita-
mins, proteins, and amino acids may explain their neu-
roprotective effects (Ng et  al., 2008; Joseph et  al., 2009; 
Xu et  al., 2009; Rest et  al., 2013). Below, we discuss the 
benefits of some foods associated with improved cogni-
tion and physical health.
Tea is understood to have overall health benefits, 
including that of reduced cognitive decline and improved 
MCI (Ng et al., 2008; Park et al., 2011). Green tea is found 
to be associated with lower rates of cognitive impairment 
(Kuriyama et  al., 2006; Ng et  al., 2008), and black fer-
mented and semifermented tea (oolong) have both been 
shown to significantly reduce cognitive decline in old age 
(Ng et al., 2008). This is possibly due to naturally occur-
ring chemical compounds such as theanine in both black 
and green tea (Ng et al., 2008; Park et al., 2011). Natural 
compounds found in various types of tea reduce ace-
tylcholinesterase activity and protect β-amyloid driven 
affects on cognition (Ng et al., 2008).
Fish may not only improve cognition but may also act 
as a neuroprotective agent against AD. Elderly individuals 
who consume fish or seafood weekly show a delay from 
4 to 7 years of developing dementia and AD (Nurk et al., 
2007). Consuming more than one serving (e.g. 100 g) of 
fresh water fish is associated with 2.5 times slower cogni-
tive decline in verbal, immediate, and delayed memory 
(Qin et al., 2014). Potential explanations of these findings 
may be omega-3 polyunsaturated fatty acids (w-3 PUFA), 
eicosapentaenoic acid (EPA), and docosahexaenoic acid 
(DHA) concentrations in fish, which have been shown to 
reduce inflammation and oxidative stress in the central 
nervous system (Qin et al., 2014). However, it is suggested 
that reduction of inflammation and stress prevents cogni-
tive decline but does not prevent or treat dementia (Qin 
et  al., 2014). Nurk et  al. (2007) also identified that both 
unprocessed fatty and lean fish lead to significant improve-
ments in overall cognitive performance. However, it is sug-
gested that consumption of fatty fish has more protective 
effects against dementia and AD than does consumption 
of lean fish (Huang et al., 2005), which may be related to 
the nutritional factors found in fatty fish such as higher 
DHA and PUFA (Zhang et al., 2016). Moreover, processed 
fish is noted to be the second most common contributor to 
improving episodic and short-term memory, visuospatial 
and motor skills, naming and recall, among other cognitive 
functions (Nurk et al., 2007). Enhanced cognition has also 
been associated with the consumption of fish oil (O’Connor 
et al., 2012), which is apparent in semantic memory, verbal 
fluency, and psychomotor speed (Nurk et al., 2007).
Various nutrients have been found to affect cognition 
differently. Vitamins C and E contained in fruits such as 
strawberries and blueberries have shown to improve verbal 
memory in middle- to old-aged individuals (Pe’neau et al., 
2011). Moderate fruit consumption is positively correlated 
with cognition in individuals with MCI (Chen et al., 2011). 
Antioxidants and polyphenolics present in some fruits 
(e.g. concord and blueberry juice) are thought to mediate 
improvements in cognitive functions such as memory by 
contributing to the reversal of aging neurons and forget-
ful behaviours typically observed in elderly individuals 
(Joseph et al., 2009).
Nuts have many benefits, including that of improving 
cognitive function (e.g. reducing memory decline) (Nooyens 
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et al., 2011). Specifically in relation to walnuts, they are sug-
gested to reduce chances of AD by managing Aβ peptides 
and protecting cells from toxicity of free damaging radicals 
with its antioxidant properties (Muthaiyah et  al., 2011). 
Walnuts, rich in polyphenol and melatonin when taken in 
moderate amounts, improve cognition (memory) and motor 
function (Willis et al., 2009), possibly because polyphenols 
reduce oxidative stress and inflammation (Poulose et  al., 
2014). Walnuts also have a high content of PUFAs (EPA 
and DHA), found to improve and maintain cell and nerve 
functioning (Yehuda et al., 2002). PUFAs enhance synap-
tic plasticity and stability of the neural membrane, which 
contributes to neural transmission, and also play a role in 
gene expression and neurogenesis (Yehuda et  al., 2002). 
Also found in walnuts is the amino acid tryptophan, which 
may improve cognitive functioning of elderly individu-
als. Tryptophan produces serotonin, improving aspects of 
verbal and short-term memory by influencing effective 
transmission of neural signals and messages to and from 
the brain (Rest et al., 2013). In Brazilian nuts, the mineral 
selenium is also suggested to be beneficial in the preven-
tion of dementia. With its antioxidant properties, selenium 
protects the body from free radicals, oxidative stress, and 
other neuropatholgoical complexities that negatively influ-
ence neurotransmission (Cardoso et  al., 2016). Brazilian 
nuts are found to reduce and restore selenium in elderly 
individuals, improving semantic verbal fluency and con-
structional praxis among other less focused cognitive func-
tions (Cardoso et al., 2016).
Turmeric (curcumin) is a natural anti-inflammatory 
plant that is used as a spice and natural herbal medicine. 
Curcumin has been shown to reduce inflammation com-
monly found in neurodegenerative diseases such as AD 
(Mishra and Palanivelu, 2008). Additionally, curcumin 
can reduce infarction, deficit, and oxidative stress and 
prevent excessive formation of amyloid plaques (Mishra 
and Palanivelu, 2008). Curcumin has effects on proteins 
and cells such as cytokines and macrophages, which have 
a crucial role in internal bodily responses against amyloid 
plaques that occur in AD (Xu et al., 2009). Curcumin also 
has beneficial effects similar to that of omega-3 fats in that 
it reduces inflammation and oxidative stress affecting the 
brain (Xu et al., 2009).
Fitness and exercise
It is suggested that physical activity reduces cognitive 
decline associated with AD (Larson, 2008). Fitness influ-
ences mental and physical well-being and is associated 
with improved cognition. Regular exercise contributes 
to protecting individuals from experiencing hippocam-
pal volume loss, brain atrophy, and declined memory, 
which are characteristics of AD (Erickson et al., 2011). 
Young individuals with high fitness levels and who 
regularly participate in cardiorespiratory fitness are 
twice less likely to develop dementia, including AD 
(Liu et al., 2011). Similar findings were found in healthy 
individuals without dementia, in that individuals with 
increased rates of daily physical activity had signifi-
cantly reduced risks of AD over 4 years (Buchman et al., 
2012). Data analyses also showed a negative correla-
tion between physical activity and decline in episodic, 
working memory and visuospatial cognitive functions 
(Buchman et al., 2012).
Furthermore, moderate participation in fitness, in 
general, specifically aerobics, protects from and reduces 
old-aged hippocampal volume loss (Erickson et al., 2011). 
Aerobic exercise is found to reverse volume loss and 
increase volume of the anterior hippocampus (Erickson 
et al., 2011). In addition, an increase in amount of grey and 
white matter of the prefrontal cortex is apparent in exer-
cise participation (Erickson et  al., 2011). Exercise is also 
assumed to be associated with increases in brain-derived 
neurotrophic factor serum levels and enhancements to 
anterior hippocampal volume, which in turn improves 
memory (Erickson et al., 2011). Thus, it can be suggested 
that exercise improves neuronal growth and cerebral 
blood flow, increases brain volume, and improves learn-
ing and memory (Sullivan, 2008; Erickson et  al., 2011). 
High levels of fitness in AD patients are also related to 
a four times reduction in brain atrophy than individu-
als with low levels of fitness. Exercise also contributes to 
increased white matter volume in the hippocampal, infe-
rior temporal gyrus, and precentralgyrus brain regions 
(Sullivan, 2008).
In sum, involvement in physical activity such as aero-
bics may improve executive control and train regions of 
the brain such as the hippocampus. This may relate to 
exercise increasing dentate gyrus cerebral blood volume, 
which improves cognition (learning) (Pereira et al., 2007). 
The benefits of fitness are important to advocate in order 
to reduce young individuals’ risks of cognitive and func-
tional impairment in later life.
Sleep
Low hours of sleep at night are also associated with lack of 
exercise (Ohayon and Vecchierini, 2005), which may result 
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in having fewer protections against cognitive decline. 
Also related is the idea that neurogenesis in individuals 
who exercise is the correlation of oxygen volume used by 
individuals (Pereira et  al., 2007), suggested to take part 
in neurogenesis, which sleep dysfunction may interrupt, 
leading to cognitive decline. In support of this idea is that 
sleep disturbance and fewer hours of sleep have also been 
shown to be risk factors for cognitive decline, demen-
tia, and AD development (Osorio et al., 2011; Spira et al., 
2014). Ohayon and Vecchierini (2005) reported obstruc-
tive sleep apnoea (OSA), rapid eye movement (REM), and 
other sleep factors as contributing to cognitive decline.
Presenting a potential relationship between OSA 
and cognitive processing is Stranks and Crowe (2016) 
suggesting impaired patients presenting worse execu-
tive function (Alchanatis et al., 2004; Ancoli-Israel et al., 
2008), specifically nonverbal memory, concept forma-
tion, and other functionality and psychomotor speed 
(Stranks and Crowe, 2016). Individuals who received 
intervention for OSA using nasal continuous positive 
airway pressure (CAP) have shown improved cognition 
in aspects of memory and executive function, which 
is suggested to be affected by interruption of breath-
ing during sleep (Ancoli-Israel et  al., 2008). The way 
in which OSA may impact on cognition includes lack 
of oxygen reaching brain tissue (hypoxia), leading to 
brain cell injury, associated with individuals’ bodily 
functioning experiencing a state of oxygen deficiency 
(anaerobic glycolysis) (Alchanatis et al., 2004). Although 
CAP apnoea machines can support breathing (oxygen 
intake) to lessen the chances of cognitive impairment, 
they cannot completely repair damage caused by OSA or 
make up for the benefits of normal, healthy sleep func-
tion (Alchanatis et al., 2004; Ancoli-Israel et al., 2008), 
which may involve the role of neurogenesis.
Another sleep factor shown to affect cognition is REM 
sleep (Ohayon and Vecchierini, 2005). Some studies show 
how REM sleep may be related to cognitive impairment in 
elderly individuals and in relation to emotional and mood 
states. In middle to elderly aged men, decreased time in 
the REM stage of sleep was associated with elevated corti-
sol during evening time of the day, contributing to memory 
decline (Van Cauter et al., 2000). It has also been reported 
that individuals with MCI are likely to develop REM sleep 
behavioural disorder (RBD) (Gagnon et al., 2012). The signs 
of cognitive impairment upon developing RBD involve 
memory, attention, and concentration dysfunction, among 
many other symptoms, which commonly occur in neuro-
degenerative diseases such as AD, Parkinson’s disease, and 
Lewy Bodies dementia (Gagnon et al., 2012).
Conclusion
Factors associated with cognitive decline in elderly indi-
viduals include personality, mood, and lifestyle. Per-
sonality and mood states either negatively or positively 
influence memory performance, most likely by affecting 
hippocampus function. The extent that factors contribute 
to risks of cognitive decline usually determines the delay 
or onset of neurodegenerative diseases such as demen-
tia and AD. Making appropriate and necessary lifestyle 
changes may minimize the risks and severity of cognitive 
decline and impairment.
In response to factors contributing to cognitive 
decline, further considerations need to be made and 
studied in the future. The findings of Katz et  al. (2016) 
emphasise the importance of considering different 
aspects of individuals’ living environment. Creating a pos-
itive environment, especially for the elderly, can lessen 
the chances of experiencing sadness, stress, anxiety, and 
similar emotions associated with cognitive decline, aMCI, 
AD, and other age-related diseases. Some necessary life-
style changes include nutrition, fitness, and the care and 
company of family, friends, and caregivers, which can 
contribute to creating a positive and socially rich envi-
ronment for elderly individuals. The significance of such 
implications involves lifestyle and environmental changes 
that not only influence mood states, personalities, symp-
toms, and disease progression but are also associated 
with brain changes.
Other factors contributing to cognitive decline that 
can be investigated in the future regard individual dif-
ferences in terms of education and language quality. 
One interesting aspect is the association of individu-
als’ level of education and age-related neurodegenera-
tive diseases (Katz et  al., 2016). Individuals who tend 
to be highly educated and use sophisticated vocabu-
lary, present good language expression of thoughts 
and ideas, and have complex sentence structure tend 
to develop dementia at a later age than usual (Marx, 
2005). On the other hand, those with poor language 
qualities suggesting low education levels indicate that 
education may be beneficial and exercise cognition, 
reducing risks of AD, thus making education and lan-
guage future interests to explore.
An additional recommendation for future work 
involves the study of the complex properties of lan-
guages. As a main form of communication, languages 
with different characteristics may influence cognitive 
reserve, decline and impairment, dementia, and AD. It 
is also important to note that how and when language 
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abilities are developed influence levels of language com-
prehension, processing, and use (Bialystok and Luk, 
2012), which, in turn, might affect levels of cognition, 
cognitive reserve, and control.
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